Loading
Hypertensive Disorder of Pregnancy · Observational Study
ClinicalTrials.gov · August 14, 2026
Early or partial results. Treat as a signal, not a conclusion.
This is a completed but unreported prospective observational cohort study of platelet phenotype in pregnant patients at high risk for preeclampsia, with blood draws planned before and during aspirin use. No results, effect sizes, or associations with adverse perinatal outcomes are disclosed in this registry record, precluding any assessment of clinical significance.
Observational. Hypertensive Disorder of Pregnancy; Female; age from 18 Years; to 50 Years. Intervention: Pregnant people at high risk of preeclampsia (case group); Pregnant people at low risk of preeclampsia (control group). n = 66. 1 site: United States.
This is a completed but unreported prospective observational cohort study of platelet phenotype in pregnant patients at high risk for preeclampsia, with blood draws planned before and during aspirin use. No results, effect sizes, or associations with adverse perinatal outcomes are disclosed in this registry record, precluding any assessment of clinical significance.
Association with adverse perinatal outcomes is stated as a study aim but not quantified or reported.
No clinical impact can be assessed from this registry entry. Results must be published separately to determine whether platelet phenotyping predicts preeclampsia or guides aspirin use in pregnancy.
Registry record of a completed observational cohort study with no results posted; design and enrollment are documented but outcomes remain unreported.
As stated by the source record.
Quoted from the source exactly as published.
No clinical impact can be assessed from this registry entry. Results must be published separately to determine whether platelet phenotyping predicts preeclampsia or guides aspirin use in pregnancy.
Graded across the dimensions that decide whether you should act, each from what the source actually supports. There is no single score, and where a dimension was not assessed it says so.
What is missing. This record has no key findings. That is a gap in the analysis, not a judgement about the study.
Registry record from ClinicalTrials.gov (NCT06194643). This is a study registration, not published results. Lead sponsor: NYU Langone Health. Recruitment status: COMPLETED. Study type: OBSERVATIONAL. Enrollment: 66 participants (ACTUAL). Conditions: Hypertensive Disorder of Pregnancy. Primary outcome measures: Number of Individuals with Overactive Platelets , Blood Draw 1 (taken between Weeks 6 and 14); Number of Individuals with Overactive Platelets , Blood Draw 2 (taken between Weeks 24 and 28). Brief summary: This is a prospective observational cohort study of platelet phenotype in pregnant patients at high-risk for the development preeclampsia. Blood samples will be collected prior to the initiation of daily aspirin and again in the second trimester to evaluate for platelet changes during pregnancy in patient's as a result of aspirin use and their association with adverse perinatal outcomes.
Taken from the source record, never inferred. Follow any of these and new work involving them reaches your briefing.